← All trials
NCT04791423
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 15, 2021
- Primary completion
- Oct 30, 2021
- Completion date
- Apr 30, 2022
- First posted
- Mar 10, 2021
- Last posted
- Jul 30, 2021
- Enrollment
- 10300
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- ReiThera SrlLead sponsor
- Istituto Nazionale Malattie Infettive Lazaro SpallanzaniCollaborator
- Istituto Nazionale Malattie Infettive Lazaro SpallanzaniOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.